Ingevity (NGVT) Tops Q1 EPS by 32c, provides guidance

Ingevity (NYSE: NGVT) reported Q1 EPS of $1.15, $0.32 better than the analyst estimate of $0.83. Revenue for the quarter came in at $258 million versus the consensus estimate of $279 million.

GUIDANCE:

Ingevity sees FY2026 EPS of $4.70-$5.20, versus the consensus of $4.80.

For earnings history and earnings-related data on Ingevity (NGVT) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• AeroVironment restates quarterly financials, citing $89M goodwill error